The defined daily dose as a tool in pharmacoeconomics. Advantages and limitations.
Clarke
K W
KW
Cardiovascular Medicine, University Hospital, Nottingham, England.
Gray
D
D
D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D004358:Drug Therapy / Q000191:economics*; D017850:Economics, Pharmaceutical; D017048:Health Care Costs; D006801:Humans